# Meta-Analysis of Single-Cell RNA-seq Data in Brain Disorders

---

## Executive Summary

Building on your lab's pioneering work in single-cell dissection of neurological and psychiatric disorders, this comprehensive plan positions your lab as the world's leading center for integrative single-cell meta-analysis of brain disorders. The plan leverages the exponential growth of public single-cell data and the powerful scverse computational ecosystem to uncover cross-disorder mechanisms, identify novel therapeutic targets, and develop predictive frameworks for disease progression.

**Key Innovation**: Systematic use of the scverse ecosystem (scanpy, squidpy, anndata, spatialdata) for reproducible, scalable analysis of >10 million cells across 7+ brain disorders.

---

## Year 1: Infrastructure, Cross-Disorder Convergence & Database Construction

### Research Questions
1. What are the shared and distinct cellular and molecular signatures across the neuropsychiatric-neurodegenerative spectrum?
2. Can we identify universal "hub" cell states that emerge across multiple disorders?
3. What is the relationship between genetic risk variants and cell-type-specific gene regulatory programs across disorders?

### Hypotheses
- **H1**: A common "stress response" microglial state exists across AD, ALS, FTD, and HD, but with disorder-specific inflammatory profiles
- **H2**: Excitatory neurons in schizophrenia, bipolar disorder, and PTSD share synaptic dysfunction signatures but differ in specific neurotransmitter system involvement
- **H3**: Oligodendrocyte dysfunction represents an underappreciated convergent mechanism across multiple disorders

### Data Sources & GEO Accession Codes

#### Alzheimer's Disease
**Primary Datasets:**
1. **GSE175814** - Single-nucleus RNA-seq of hippocampus from Braak stage I-II patients
   - 25,000+ nuclei from 2 AD and 2 control samples
   - Reference: Soreq et al. (2023). PLOS ONE. DOI: 10.1371/journal.pone.0277630

2. **ssREAD Database** (http://ssread.coh.org)
   - 1,053 samples (277 integrated datasets) from 67 studies
   - 7,332,202 cells total
   - 381 spatial transcriptomics datasets from 18 studies
   - Reference: Wang et al. (2024). Nat Commun. 15:4710. DOI: 10.1038/s41467-024-49133-z

3. **ROSMAP snRNA-seq** - Multiregion atlas
   - 1.3 million cells from 283 samples, 48 individuals
   - 6 brain regions (prefrontal, temporal, parietal cortex, entorhinal, thalamus, hippocampus)
   - Reference: Mathys et al. (2024). Nature. DOI: 10.1038/s41586-024-07606-7

4. **Prefrontal Cortex Atlas** (GSE214979)
   - 80,660 single-nuclei from 48 individuals
   - Reference: Mathys et al. (2019). Nature. 570:332-337. DOI: 10.1038/s41586-019-1195-2

5. **DIAN & C&F Dataset** - Autosomal dominant AD
   - Parietal cortex snRNA-seq and snATAC-seq
   - Reference: Miyoshi et al. (2023). Nat Commun. 14:2314. DOI: 10.1038/s41467-023-37437-5

**Spatial Datasets:**
6. **10x Visium Spatial AD Dataset**
   - Prefrontal cortex from controls, early AD, late AD, Down Syndrome AD
   - Reference: Lee et al. (2024). Nat Genet. DOI: 10.1038/s41588-024-01961-x

#### Schizophrenia
**Primary Datasets:**
1. **PsychENCODE Multi-cohort Dataset**
   - 468,727 nuclei from 140 individuals (McLean + MSSM cohorts)
   - 25 cell types identified
   - Reference: Ruzicka et al. (2024). Science. 384:eadg5136. DOI: 10.1126/science.adg5136

2. **Prefrontal Cortex snRNA-seq** (medRxiv preprint data)
   - 500,000+ cells from 48 samples (24 SCZ, 24 controls)
   - Reference: Ruzicka et al. (2020). medRxiv. DOI: 10.1101/2020.11.06.20225342

3. **Cell-type eQTL data** 
   - 196 individuals, 8 major CNS cell types
   - Reference: Wu et al. (2023). Schizophr Bull. 49(4):914-922. DOI: 10.1093/schbul/sbad002

**Spatial Datasets:**
4. **Visium DLPFC Dataset**
   - Layer-specific gene expression
   - Reference: Maynard et al. (2021). Nat Neurosci. 24:425-436. DOI: 10.1038/s41593-020-00787-0

#### ALS & FTD
**Primary Datasets:**
1. **Motor & Prefrontal Cortex Dataset**
   - snRNA-seq from sporadic and familial ALS/FTLD
   - Layer 5 vulnerable populations
   - Reference: Pineda et al. (2024). Cell. DOI: 10.1016/j.cell.2024.02.031

2. **C9orf72 Mutation Carriers** (GSE226326)
   - snRNA-seq and snATAC-seq from motor and frontal cortices
   - Reference: Tam et al. (2023). Nat Commun. 14:5263. DOI: 10.1038/s41467-023-41033-y

3. **RiMod-FTD Multi-omics Dataset** (figshare: 10.6084/m9.figshare.23825595)
   - RNA-seq, CAGE-seq, smRNA-seq, methylation
   - MAPT, GRN, C9orf72 subtypes
   - Reference: Menden et al. (2023). Sci Data. 10:804. DOI: 10.1038/s41597-023-02598-x

4. **FTLD-TDP Transcriptomic Dataset**
   - Frontal cortex, temporal cortex, cerebellum
   - 30 FTLD-TDP patients, 28 controls
   - Reference: Humphrey et al. (2022). Acta Neuropathol. 143(3):383-401

5. **Synapse ALS-FTD Project** (syn45351388)
   - Comprehensive single-nuclei sequencing resource

6. **MAPT Carriers scRNA-seq** (AD Workbench)
   - 181,000 immune cells from blood
   - 8 FTD-MAPT carriers vs 8 controls
   - Available through: AD Connect platform

#### Parkinson's Disease
**Primary Datasets:**
1. **Substantia Nigra snRNA-seq**
   - 84,000 nuclei from 29 samples (15 PD, 14 controls)
   - Reference: Trzaskoma et al. (2024). Mol Neurodegener. 19:7. DOI: 10.1186/s13024-023-00699-0

2. **iPSC-derived Dopamine Neurons**
   - GBA-N370S patients bulk and scRNA-seq
   - Reference: Lang et al. (2019). Cell Stem Cell. 24:135-150

#### Huntington's Disease
**Primary Datasets:**
1. **Striatal Neuron snRNA-seq**
   - Human and rodent models
   - Reference: Matsushima et al. (2023). Nat Commun. 14:282. DOI: 10.1038/s41467-022-35628-4

2. **BA4 Motor Cortex RNA-seq**
   - Transcriptome-wide analysis
   - Reference: Sneha et al. (2023). Genes. 14(9):1801

#### PTSD & Psychiatric Disorders
**Primary Datasets:**
1. **Cross-disorder Blood RNA-seq**
   - PTSD, PD, Schizophrenia comparison
   - Reference: de Vries et al. (2022). Discov Mental Health. 2:4. DOI: 10.1007/s44192-022-00009-y

2. **PsychENCODE PTSD Dataset**
   - Brain regions, cell types, blood analysis
   - Reference: Daskalakis et al. (2024). Science. 384:eadh3707

### Additional Data Resources

**Comprehensive Databases:**
1. **Single Cell Portal** (Broad Institute): https://singlecell.broadinstitute.org
   - 500+ brain studies

2. **Gene Expression Omnibus (GEO)**: https://www.ncbi.nlm.nih.gov/geo/
   - Search terms: "single cell", "brain", specific disorder names

3. **AD Knowledge Portal**: https://adknowledgeportal.org
   - ROSMAP, MSBB, Mayo single-cell cohorts

4. **Allen Brain Cell Atlas**: https://portal.brain-map.org
   - Comprehensive reference atlases

5. **BRAIN Initiative Cell Census Network (BICCN)**: https://biccn.org
   - Human and mouse brain cell atlases

6. **PsychENCODE**: http://psychencode.org
   - Psychiatric disorder multi-omics data

### Computational Infrastructure: scverse Ecosystem

#### Core Tools
1. **anndata** (v0.10+)
   - Data structure for storing annotated data matrices
   - Installation: `pip install anndata`
   - Documentation: https://anndata.readthedocs.io

2. **scanpy** (v1.10+)
   - Core single-cell analysis toolkit
   - Installation: `pip install scanpy`
   - Documentation: https://scanpy.readthedocs.io

3. **squidpy** (v1.4+)
   - Spatial omics analysis
   - Installation: `pip install squidpy`
   - Documentation: https://squidpy.readthedocs.io

4. **spatialdata** (v0.1+)
   - Universal framework for spatial omics
   - Installation: `pip install spatialdata`
   - Reference: Marconato et al. (2024). Nat Methods. DOI: 10.1038/s41592-024-02212-x

5. **muon** (v0.1+)
   - Multimodal omics analysis
   - Installation: `pip install muon`
   - Reference: Bredikhin et al. (2022). Genome Biol. 23:42

6. **rapids-singlecell** (v0.10+)
   - GPU-accelerated analysis (10-100x speedup)
   - Installation: `pip install rapids-singlecell`
   - Documentation: https://rapids-singlecell.readthedocs.io

#### Supporting Tools
7. **scvi-tools** - Deep learning models for single-cell
8. **pertpy** - Perturbation analysis framework
9. **decoupler** - Enrichment statistical methods
10. **scirpy** - TCR/BCR repertoire analysis

### Year 1 Protocol: Database Construction Using scverse

#### Step 1: Data Acquisition and Standardization

```python
import scanpy as sc
import anndata as ad
import pandas as pd
import numpy as np
from pathlib import Path

# Configuration
sc.settings.verbosity = 3
sc.settings.set_figure_params(dpi=80, facecolor='white')

# Step 1.1: Download datasets from GEO/repositories
# Use GEOparse or manual download
def download_geo_dataset(geo_id, output_dir):
    """Download and parse GEO dataset"""
    import GEOparse
    gse = GEOparse.get_GEO(geo=geo_id, destdir=output_dir)
    return gse

# Step 1.2: Load individual datasets
def load_dataset(file_path, dataset_name):
    """Load single-cell dataset into AnnData format"""
    if file_path.endswith('.h5ad'):
        adata = sc.read_h5ad(file_path)
    elif file_path.endswith('.h5'):
        adata = sc.read_10x_h5(file_path)
    elif file_path.endswith('.mtx'):
        adata = sc.read_mtx(file_path)
    
    # Add dataset metadata
    adata.obs['dataset'] = dataset_name
    adata.obs['source'] = 'GEO' if 'GSE' in dataset_name else 'Other'
    
    return adata

# Step 1.3: Standardize gene names
def standardize_genes(adata):
    """Convert all gene names to standard nomenclature"""
    # Use biomart or mygene for gene name conversion
    import mygene
    mg = mygene.MyGeneInfo()
    
    # Convert to official gene symbols
    gene_list = adata.var_names.tolist()
    results = mg.querymany(gene_list, scopes='symbol,ensembl.gene', 
                          fields='symbol', species='human')
    
    # Update gene names
    gene_dict = {r['query']: r.get('symbol', r['query']) 
                for r in results if 'symbol' in r}
    adata.var_names = [gene_dict.get(g, g) for g in adata.var_names]
    adata.var_names_make_unique()
    
    return adata
```

#### Step 2: Quality Control Pipeline

```python
def qc_metrics(adata, species='human'):
    """Calculate comprehensive QC metrics"""
    
    # Basic QC metrics
    sc.pp.calculate_qc_metrics(
        adata, 
        qc_vars=['mt', 'ribo'],
        percent_top=None,
        log1p=False,
        inplace=True
    )
    
    # Mitochondrial genes
    adata.var['mt'] = adata.var_names.str.startswith('MT-')
    
    # Ribosomal genes
    adata.var['ribo'] = adata.var_names.str.startswith(('RPS', 'RPL'))
    
    # Calculate percentages
    sc.pp.calculate_qc_metrics(
        adata, 
        qc_vars=['mt', 'ribo'], 
        percent_top=None,
        log1p=False, 
        inplace=True
    )
    
    return adata

def apply_qc_filters(adata, min_genes=200, min_cells=3, 
                     max_pct_mt=20, max_counts=None):
    """Apply standard QC filters"""
    
    print(f"Cells before filtering: {adata.n_obs}")
    
    # Filter cells
    sc.pp.filter_cells(adata, min_genes=min_genes)
    
    # Filter genes
    sc.pp.filter_genes(adata, min_cells=min_cells)
    
    # Filter by mitochondrial percentage
    adata = adata[adata.obs.pct_counts_mt < max_pct_mt, :]
    
    # Optional: filter by total counts
    if max_counts:
        adata = adata[adata.obs.n_genes_by_counts < max_counts, :]
    
    print(f"Cells after filtering: {adata.n_obs}")
    
    return adata
```

#### Step 3: Batch Correction and Integration

```python
import scanpy.external as sce

def integrate_datasets(adata_list, method='scvi', batch_key='dataset'):
    """Integrate multiple datasets using various methods"""
    
    # Concatenate datasets
    adata_combined = ad.concat(adata_list, label=batch_key, 
                               keys=[a.obs[batch_key][0] for a in adata_list])
    
    # Preprocessing
    sc.pp.normalize_total(adata_combined, target_sum=1e4)
    sc.pp.log1p(adata_combined)
    sc.pp.highly_variable_genes(adata_combined, n_top_genes=3000, 
                                batch_key=batch_key)
    
    if method == 'scvi':
        # scVI integration (recommended for large-scale)
        import scvi
        scvi.model.SCVI.setup_anndata(adata_combined, batch_key=batch_key)
        vae = scvi.model.SCVI(adata_combined)
        vae.train()
        adata_combined.obsm["X_scVI"] = vae.get_latent_representation()
        sc.pp.neighbors(adata_combined, use_rep="X_scVI")
        
    elif method == 'harmony':
        # Harmony integration
        sc.external.pp.harmony_integrate(adata_combined, batch_key)
        
    elif method == 'scanorama':
        # Scanorama integration
        sce.pp.scanorama_integrate(adata_combined, batch_key)
    
    return adata_combined

# Alternative: Use rapids-singlecell for GPU acceleration
def integrate_datasets_gpu(adata_list, batch_key='dataset'):
    """GPU-accelerated integration"""
    import rapids_singlecell as rsc
    
    adata_combined = ad.concat(adata_list, label=batch_key)
    
    # GPU-accelerated preprocessing
    rsc.pp.normalize_total(adata_combined, target_sum=1e4)
    rsc.pp.log1p(adata_combined)
    rsc.pp.highly_variable_genes(adata_combined, n_top_genes=3000)
    
    # GPU-accelerated PCA
    rsc.pp.pca(adata_combined)
    
    # GPU-accelerated batch correction (using harmony)
    rsc.pp.harmony_integrate(adata_combined, key=batch_key)
    
    return adata_combined
```

#### Step 4: Cell Type Annotation

```python
def annotate_cell_types(adata, reference_adata=None, method='automated'):
    """Annotate cell types using reference-based or marker-based approaches"""
    
    if method == 'automated' and reference_adata:
        # Use scANVI for automated annotation
        import scvi
        
        scvi.model.SCANVI.setup_anndata(adata, batch_key='dataset')
        scanvi_model = scvi.model.SCANVI.load_query_data(
            adata, reference_adata
        )
        scanvi_model.train(max_epochs=20)
        adata.obs['predicted_celltype'] = scanvi_model.predict()
        
    elif method == 'markers':
        # Marker-based annotation
        marker_genes = {
            'Excitatory_Neurons': ['SLC17A7', 'CAMK2A', 'SATB2'],
            'Inhibitory_Neurons': ['GAD1', 'GAD2', 'SLC32A1'],
            'Astrocytes': ['AQP4', 'GFAP', 'SLC1A3'],
            'Oligodendrocytes': ['MBP', 'MOG', 'PLP1'],
            'OPC': ['PDGFRA', 'CSPG4', 'SOX10'],
            'Microglia': ['CSF1R', 'CX3CR1', 'P2RY12', 'TMEM119'],
            'Endothelial': ['CLDN5', 'FLT1', 'VWF'],
            'Pericytes': ['PDGFRB', 'RGS5', 'ACTA2']
        }
        
        # Calculate marker scores
        for celltype, markers in marker_genes.items():
            sc.tl.score_genes(adata, markers, 
                            score_name=f'{celltype}_score')
        
        # Assign cell types based on highest score
        score_cols = [col for col in adata.obs.columns if '_score' in col]
        adata.obs['celltype'] = adata.obs[score_cols].idxmax(axis=1)
        adata.obs['celltype'] = adata.obs['celltype'].str.replace('_score', '')
    
    return adata
```

#### Step 5: Create Harmonized Database

```python
def create_harmonized_database(adata, output_dir):
    """Save processed, harmonized database"""
    
    # Add comprehensive metadata
    adata.uns['database_version'] = '1.0'
    adata.uns['creation_date'] = pd.Timestamp.now().isoformat()
    adata.uns['n_datasets'] = len(adata.obs['dataset'].unique())
    adata.uns['disorders'] = list(adata.obs['disorder'].unique())
    
    # Save in multiple formats
    # 1. Full AnnData object
    adata.write_h5ad(f'{output_dir}/harmonized_brain_disorders.h5ad')
    
    # 2. Backed mode for large-scale access
    adata.write_h5ad(f'{output_dir}/harmonized_brain_disorders_backed.h5ad',
                     compression='gzip')
    
    # 3. Export metadata
    adata.obs.to_csv(f'{output_dir}/metadata.csv')
    adata.var.to_csv(f'{output_dir}/genes.csv')
    
    # 4. Create subset versions for quick access
    for disorder in adata.obs['disorder'].unique():
        subset = adata[adata.obs['disorder'] == disorder].copy()
        subset.write_h5ad(f'{output_dir}/{disorder}_subset.h5ad')
    
    return adata
```

### Key Publications for Year 1

1. **Mathys H, et al.** (2024). Single-cell multiregion dissection of Alzheimer's disease. *Nature*. DOI: 10.1038/s41586-024-07606-7

2. **Wang C, et al.** (2024). A single-cell and spatial RNA-seq database for Alzheimer's disease (ssREAD). *Nat Commun*. 15:4710.

3. **Ruzicka WB, et al.** (2024). Single-cell multi-cohort dissection of the schizophrenia transcriptome. *Science*. 384:eadg5136.

4. **Pineda SS, et al.** (2024). Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD. *Cell*. DOI: 10.1016/j.cell.2024.02.031

5. **Trzaskoma P, et al.** (2024). Unravelling cell type-specific responses to Parkinson's Disease at single cell resolution. *Mol Neurodegener*. 19:7.

6. **Wolf FA, et al.** (2018). SCANPY: large-scale single-cell gene expression data analysis. *Genome Biol*. 19:15.

7. **Palla G, et al.** (2022). Squidpy: a scalable framework for spatial omics analysis. *Nat Methods*. 19:171-178.

8. **Virshup I, et al.** (2023). The scverse project provides a computational ecosystem for single-cell omics data analysis. *Nat Biotechnol*. 41:604-606.

### Deliverables Year 1

1. **Harmonized Database**
   - 200+ datasets integrated
   - >10 million cells with standardized annotations
   - Cell-type specific markers defined across disorders

2. **Interactive Web Portal**
   - Browser-based exploration using cellxgene
   - Query interface for cross-disorder comparisons
   - Download functionality for subsets

3. **Publications** (2-3 high-impact papers)
   - Paper 1: "Cross-disorder single-cell atlas of neuropsychiatric diseases"
   - Paper 2: "Convergent microglial states across neurodegenerative disorders"
   - Paper 3: "scverse-based framework for large-scale meta-analysis"

4. **Open-source Pipeline**
   - GitHub repository with analysis workflows
   - Documentation and tutorials
   - Docker containers for reproducibility

---

## Year 2: Spatial Context & Cell-Cell Communication Networks

### Research Questions
1. How do cell-cell communication networks differ between disorders?
2. What are the spatial organizing principles of pathology propagation?
3. Can we identify critical cellular "hubs" that coordinate disease responses?

### Hypotheses
- **H1**: Microglia-astrocyte-neuron communication triads show disorder-specific rewiring patterns
- **H2**: Spatial proximity of activated microglia to specific neuronal subtypes predicts vulnerability in AD vs FTD
- **H3**: Oligodendrocyte-astrocyte interactions are disrupted in white matter regions across multiple disorders

### Data Sources - Spatial Transcriptomics

#### 10x Visium Datasets

1. **Human DLPFC Spatial Atlas**
   - 12 tissue sections from 3 neurotypical donors
   - 6 cortical layers defined
   - Reference: Maynard et al. (2021). *Nat Neurosci*. 24:425-436

2. **AD Spatial Transcriptomics**
   - Controls, early AD, late AD, Down Syndrome AD
   - Prefrontal cortex Visium data
   - Reference: Lee et al. (2024). *Nat Genet*. DOI: 10.1038/s41588-024-01961-x

3. **PsychENCODE Spatial Data**
   - DLPFC across development and disease
   - Reference: Maynard et al. (2024). *Science*. 384:eadh1938

#### MERFISH/seqFISH Datasets

4. **High-resolution Spatial Datasets**
   - Available through BRAIN Initiative
   - Subcellular resolution imaging

#### Slide-seq Datasets

5. **Mouse and Human Brain Slide-seq**
   - 10Î¼m resolution spatial transcriptomics
   - Multiple brain regions

### Year 2 Protocol: Spatial Analysis Using squidpy

#### Step 1: Load and Process Spatial Data

```python
import squidpy as sq
import scanpy as sc
import matplotlib.pyplot as plt

def load_visium_data(visium_dir, sample_id):
    """Load 10x Visium spatial transcriptomics data"""
    
    # Load data
    adata = sc.read_visium(visium_dir, 
                          count_file=f'{sample_id}_filtered_feature_bc_matrix.h5',
                          library_id=sample_id)
    
    # Load high-resolution image
    adata.uns['spatial'][sample_id]['images']['hires'] = plt.imread(
        f'{visium_dir}/spatial/tissue_hires_image.png'
    )
    
    # Calculate QC metrics
    sc.pp.calculate_qc_metrics(adata, inplace=True)
    
    return adata

def preprocess_spatial(adata):
    """Standard preprocessing for spatial data"""
    
    # Filter
    sc.pp.filter_genes(adata, min_cells=10)
    
    # Normalize
    sc.pp.normalize_total(adata, target_sum=1e4)
    sc.pp.log1p(adata)
    
    # Find highly variable genes
    sc.pp.highly_variable_genes(adata, n_top_genes=3000)
    
    # Scale
    sc.pp.scale(adata)
    
    # PCA
    sc.pp.pca(adata, n_comps=50)
    
    # Clustering
    sc.pp.neighbors(adata)
    sc.tl.leiden(adata, key_added='clusters')
    sc.tl.umap(adata)
    
    return adata
```

#### Step 2: Spatial Statistics

```python
def calculate_spatial_statistics(adata):
    """Calculate spatial autocorrelation and co-localization"""
    
    # Build spatial neighbor graph
    sq.gr.spatial_neighbors(adata, coord_type='generic', n_neighs=6)
    
    # Calculate spatial autocorrelation (Moran's I)
    sq.gr.spatial_autocorr(
        adata,
        mode='moran',
        n_perms=100,
        n_jobs=-1
    )
    
    # Calculate neighborhood enrichment
    sq.gr.nhood_enrichment(adata, cluster_key='clusters')
    
    # Calculate co-occurrence
    sq.gr.co_occurrence(
        adata,
        cluster_key='clusters'
    )
    
    # Calculate centrality scores
    sq.gr.centrality_scores(adata, cluster_key='clusters')
    
    return adata

# GPU-accelerated version
def calculate_spatial_statistics_gpu(adata):
    """GPU-accelerated spatial statistics"""
    import rapids_singlecell as rsc
    
    # Spatial neighbors (GPU)
    sq.gr.spatial_neighbors(adata)
    
    # Moran's I (GPU-accelerated)
    rsc.gr.spatial_autocorr(adata, mode='moran')
    
    return adata
```

#### Step 3: Cell-Cell Communication Analysis

```python
import squidpy as sq

def analyze_ligand_receptor(adata, cluster_key='cell_type'):
    """Analyze ligand-receptor interactions"""
    
    # Load ligand-receptor database
    # Options: 'consensus', 'cellphonedb', 'connectomedb2020', 'omnipath'
    sq.gr.ligrec(
        adata,
        cluster_key=cluster_key,
        interactions_params={'resources': 'consensus'},
        n_perms=1000,
        threshold=0.1
    )
    
    return adata

def analyze_cellchat(adata):
    """Alternative: Use CellChat through Python interface"""
    
    # This requires R installation with CellChat
    import rpy2.robjects as ro
    from rpy2.robjects import pandas2ri
    pandas2ri.activate()
    
    # Convert to R object and run CellChat
    # Implementation depends on specific requirements
    
    pass

def create_communication_network(adata, cluster_key='cell_type'):
    """Create cell-cell communication networks"""
    
    # Calculate communication strength
    sq.gr.ligrec(adata, cluster_key=cluster_key)
    
    # Create network visualization
    sq.pl.ligrec(adata, cluster_key=cluster_key, 
                source_groups=['Microglia'],
                target_groups=['Astrocytes', 'Neurons'])
    
    # Export network for external analysis
    import networkx as nx
    
    # Build NetworkX graph
    lr_means = adata.uns['ligrec']['means']
    G = nx.from_pandas_adjacency(lr_means)
    
    # Save network
    nx.write_gpickle(G, 'communication_network.gpickle')
    
    return G
```

#### Step 4: Spatial Domains & Niches

```python
def identify_spatial_domains(adata, method='leiden'):
    """Identify spatially coherent domains"""
    
    if method == 'leiden':
        # Leiden clustering on spatial graph
        sq.gr.spatial_neighbors(adata)
        sc.tl.leiden(adata, resolution=0.5, key_added='spatial_domains')
        
    elif method == 'deep_learning':
        # Use STAGATE or GraphST
        import STAGATE
        
        # Preprocess
        STAGATE.Cal_Spatial_Net(adata, rad_cutoff=150)
        STAGATE.Stats_Spatial_Net(adata)
        
        # Train model
        adata = STAGATE.train_STAGATE(adata)
        
        # Clustering
        sc.pp.neighbors(adata, use_rep='STAGATE')
        sc.tl.leiden(adata, key_added='spatial_domains')
    
    return adata

def characterize_niches(adata, domain_key='spatial_domains'):
    """Characterize cellular niches"""
    
    # Calculate niche composition
    niche_composition = pd.crosstab(
        adata.obs[domain_key],
        adata.obs['cell_type'],
        normalize='index'
    )
    
    # Find marker genes for each niche
    sc.tl.rank_genes_groups(adata, domain_key, method='wilcoxon')
    
    # Calculate niche-specific enrichment scores
    for niche in adata.obs[domain_key].unique():
        markers = sc.get.rank_genes_groups_df(
            adata, group=niche, key='rank_genes_groups'
        ).head(50)['names'].tolist()
        
        sc.tl.score_genes(adata, markers, 
                         score_name=f'niche_{niche}_score')
    
    return adata
```

#### Step 5: Spatial Deconvolution

```python
def deconvolve_spots(adata_spatial, adata_scrna):
    """Deconvolve spatial spots using scRNA-seq reference"""
    
    # Method 1: Cell2location
    import cell2location
    
    # Prepare reference
    cell2location.models.RegressionModel.setup_anndata(
        adata=adata_scrna,
        labels_key='cell_type'
    )
    
    # Train reference model
    mod_ref = cell2location.models.RegressionModel(adata_scrna)
    mod_ref.train(max_epochs=250)
    
    # Export signatures
    adata_scrna = mod_ref.export_posterior(adata_scrna)
    
    # Run cell2location on spatial data
    cell2location.models.Cell2location.setup_anndata(adata=adata_spatial)
    
    mod_spatial = cell2location.models.Cell2location(
        adata_spatial,
        cell_state_df=adata_scrna.varm['means_cell_type_expression'],
        N_cells_per_location=30
    )
    
    mod_spatial.train(max_epochs=30000)
    adata_spatial = mod_spatial.export_posterior(adata_spatial)
    
    # Method 2: RCTD (alternative)
    # Requires spacexr R package
    
    return adata_spatial
```

### Key Publications for Year 2

9. **Palla G, et al.** (2022). Squidpy: a scalable framework for spatial omics analysis. *Nat Methods*. 19:171-178.

10. **Marconato L, et al.** (2024). SpatialData: an open and universal data framework for spatial omics. *Nat Methods*. DOI: 10.1038/s41592-024-02212-x

11. **Maynard KR, et al.** (2024). A data-driven single-cell and spatial transcriptomic map of the human prefrontal cortex. *Science*. 384:eadh1938.

12. **Lee EB, et al.** (2024). Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer's disease. *Nat Genet*. DOI: 10.1038/s41588-024-01961-x

13. **Kleshchevnikov V, et al.** (2022). Cell2location maps fine-grained cell types in spatial transcriptomics. *Nat Biotechnol*. 40:661-671.

14. **Jin S, et al.** (2024). CellChat for systematic analysis of cell-cell communication from single-cell and spatially resolved transcriptomics. *bioRxiv*.

### Deliverables Year 2

1. **Spatial Cell Communication Atlas**
   - Ligand-receptor networks for 6+ disorders
   - Spatial interaction maps
   - Niche characterization

2. **Publications** (3-4 papers)
   - "Spatial organization of pathology in neurodegeneration"
   - "Cell-cell communication rewiring in psychiatric disorders"
   - "Microenvironment influences on cellular vulnerability"

3. **Software Package**
   - `brainspace`: Extension to squidpy for brain-specific analysis
   - Integration of communication and spatial analysis

---

## Year 3: Temporal Dynamics & Disease Progression Trajectories

### Research Questions
1. What are the earliest detectable cellular changes preceding clinical symptoms?
2. How do cellular states evolve during disease progression?
3. Can we identify critical transition points or "tipping points" in disease trajectories?

### Hypotheses
- **H1**: Homeostatic microglia transition to "primed" state years before disease-associated microglia (DAM) emergence
- **H2**: Synaptic gene expression changes in excitatory neurons precede neuronal loss by months-years
- **H3**: Astrocyte reactivity follows stereotyped progression pathway across neurodegenerative disorders but with different kinetics

### Data Sources - Longitudinal & Staged Cohorts

#### Human Longitudinal Cohorts

1. **ROSMAP with Staged Pathology**
   - Braak staging I-VI
   - CERAD scores
   - Reference: Bennett et al. (2018). *J Alzheimers Dis*. 64:S567-S587

2. **DIAN - Dominantly Inherited Alzheimer Network**
   - Preclinical to symptomatic stages
   - Available through: https://dian.wustl.edu

3. **ADNI - Alzheimer's Disease Neuroimaging Initiative**
   - Longitudinal clinical data with molecular samples
   - https://adni.loni.usc.edu

#### Age-Stratified Datasets

4. **Aging Brain Single-Cell Studies**
   - 20-90+ years age range
   - Multiple brain regions

5. **Developmental to Aging Trajectories**
   - Pediatric to adult datasets
   - PsychENCODE developmental data

#### Model Systems

6. **Mouse Temporal Sampling**
   - 5XFAD (AD model): Multiple timepoints
   - SOD1 (ALS model): Disease progression
   - R6/2 (HD model): Phenotype evolution

7. **iPSC-derived Organoid Time Series**
   - In vitro disease modeling
   - Controlled temporal sampling

### Year 3 Protocol: Trajectory Inference Using scverse

#### Step 1: Pseudotime Analysis

```python
import scanpy as sc
import scvelo as scv
import cellrank as cr

def infer_trajectories(adata, root_cells=None):
    """Infer developmental/disease trajectories"""
    
    # Method 1: Diffusion pseudotime
    sc.tl.diffmap(adata)
    sc.tl.dpt(adata, n_dcs=10)
    
    if root_cells:
        adata.uns['iroot'] = root_cells[0]
        sc.tl.dpt(adata)
    
    # Method 2: PAGA (Partition-based graph abstraction)
    sc.tl.paga(adata, groups='cell_type')
    sc.pl.paga(adata, color='cell_type')
    
    # Initialize positions using PAGA
    sc.tl.umap(adata, init_pos='paga')
    
    # Method 3: Slingshot (via rpy2)
    # Requires R installation with slingshot package
    
    return adata

def rna_velocity_analysis(adata_spliced, adata_unspliced):
    """RNA velocity analysis for trajectory inference"""
    
    # Merge spliced and unspliced counts
    adata = adata_spliced.copy()
    adata.layers['spliced'] = adata_spliced.X
    adata.layers['unspliced'] = adata_unspliced.X
    
    # Preprocessing
    scv.pp.filter_and_normalize(adata, min_shared_counts=20, n_top_genes=2000)
    scv.pp.moments(adata, n_pcs=30, n_neighbors=30)
    
    # Velocity estimation
    scv.tl.velocity(adata, mode='stochastic')
    scv.tl.velocity_graph(adata)
    
    # Visualization
    scv.pl.velocity_embedding_stream(adata, basis='umap')
    
    # Latent time inference
    scv.tl.latent_time(adata)
    
    # Velocity confidence
    scv.tl.velocity_confidence(adata)
    
    return adata

def cellrank_analysis(adata):
    """CellRank for fate mapping and driver gene identification"""
    
    # Compute velocity kernel
    vk = cr.kernels.VelocityKernel(adata)
    vk.compute_transition_matrix()
    
    # Compute connectivity kernel
    ck = cr.kernels.ConnectivityKernel(adata)
    ck.compute_transition_matrix()
    
    # Combine kernels
    combined_kernel = 0.8 * vk + 0.2 * ck
    
    # Estimate fate probabilities
    estimator = cr.estimators.GPCCA(combined_kernel)
    estimator.compute_macrostates(n_states=4)
    estimator.compute_fate_probabilities()
    
    # Identify driver genes
    estimator.compute_lineage_drivers(lineages='terminal_state')
    
    return adata, estimator
```

#### Step 2: Multi-timepoint Integration

```python
def integrate_temporal_data(adata_dict, timepoint_key='timepoint'):
    """Integrate data across multiple timepoints"""
    
    # Add timepoint information
    for tp, adata in adata_dict.items():
        adata.obs[timepoint_key] = tp
    
    # Concatenate
    adata_combined = ad.concat(adata_dict.values(), 
                              label=timepoint_key,
                              keys=list(adata_dict.keys()))
    
    # Integration preserving temporal structure
    import scvi
    
    scvi.model.SCVI.setup_anndata(
        adata_combined,
        batch_key=timepoint_key,
        categorical_covariate_keys=['donor', 'condition']
    )
    
    vae = scvi.model.SCVI(adata_combined, n_latent=30)
    vae.train()
    
    adata_combined.obsm["X_scVI"] = vae.get_latent_representation()
    
    return adata_combined

def trajectory_differential_expression(adata, pseudotime_key='dpt_pseudotime'):
    """Find genes that change along trajectories"""
    
    # Generalized additive models for trajectory DE
    import mgcv
    # or use scanpy's built-in methods
    
    # Rank genes by pseudotime correlation
    sc.tl.rank_genes_groups(adata, groupby=pseudotime_key, 
                           method='logreg')
    
    # Smooth gene expression along pseudotime
    from scipy.interpolate import UnivariateSpline
    
    genes_of_interest = adata.var_names[:100]  # Top variable genes
    pseudotime = adata.obs[pseudotime_key].values
    
    smoothed_expression = {}
    for gene in genes_of_interest:
        expr = adata[:, gene].X.toarray().flatten()
        # Sort by pseudotime
        sorted_idx = np.argsort(pseudotime)
        spline = UnivariateSpline(
            pseudotime[sorted_idx], 
            expr[sorted_idx], 
            s=1
        )
        smoothed_expression[gene] = spline(pseudotime)
    
    return smoothed_expression
```

#### Step 3: Disease Staging

```python
def create_disease_clock(adata, stages, stage_key='disease_stage'):
    """Create cellular clock for disease staging"""
    
    # Train classifier on known stages
    from sklearn.ensemble import RandomForestClassifier
    from sklearn.model_selection import cross_val_score
    
    # Get PCA representation
    X = adata.obsm['X_pca']
    y = adata.obs[stage_key].astype('category').cat.codes
    
    # Train model
    clf = RandomForestClassifier(n_estimators=100, random_state=42)
    clf.fit(X, y)
    
    # Get feature importance
    importances = clf.feature_importances_
    
    # Predict stages for unlabeled samples
    adata.obs['predicted_stage'] = clf.predict(X)
    adata.obs['stage_probability'] = clf.predict_proba(X).max(axis=1)
    
    # Extract staging signatures
    staging_genes = {}
    for stage in stages:
        mask = adata.obs[stage_key] == stage
        sc.tl.rank_genes_groups(
            adata, 
            groupby=stage_key,
            groups=[stage],
            reference='rest'
        )
        staging_genes[stage] = sc.get.rank_genes_groups_df(
            adata, group=stage
        ).head(50)['names'].tolist()
    
    return adata, staging_genes

def compute_progression_score(adata, early_genes, late_genes):
    """Compute disease progression score"""
    
    # Early disease signature
    sc.tl.score_genes(adata, early_genes, 
                     score_name='early_disease_score')
    
    # Late disease signature
    sc.tl.score_genes(adata, late_genes, 
                     score_name='late_disease_score')
    
    # Composite progression score
    adata.obs['progression_score'] = (
        adata.obs['late_disease_score'] - 
        adata.obs['early_disease_score']
    )
    
    return adata
```

#### Step 4: Cross-species Validation

```python
def cross_species_integration(adata_human, adata_mouse):
    """Integrate human and mouse data for validation"""
    
    # Use SAMap for cross-species alignment
    import samap
    
    # Or use SCVI with species as batch
    import scvi
    
    # Add species label
    adata_human.obs['species'] = 'human'
    adata_mouse.obs['species'] = 'mouse'
    
    # Convert mouse genes to human orthologs
    # Use biomart or prepared ortholog tables
    import mygene
    mg = mygene.MyGeneInfo()
    
    mouse_genes = adata_mouse.var_names.tolist()
    orthologs = mg.querymany(
        mouse_genes,
        scopes='symbol',
        fields='ortholog.human.symbol',
        species='mouse'
    )
    
    # Create ortholog mapping
    ortholog_dict = {}
    for result in orthologs:
        if 'ortholog' in result and 'human' in result['ortholog']:
            ortholog_dict[result['query']] = result['ortholog']['human']['symbol']
    
    # Filter to common genes
    common_genes = list(set(adata_human.var_names) & 
                       set(ortholog_dict.values()))
    
    adata_human_subset = adata_human[:, common_genes]
    adata_mouse_subset = adata_mouse[:, 
                        [k for k, v in ortholog_dict.items() 
                         if v in common_genes]]
    
    # Rename mouse genes to human orthologs
    adata_mouse_subset.var_names = [ortholog_dict[g] 
                                    for g in adata_mouse_subset.var_names]
    
    # Concatenate and integrate
    adata_combined = ad.concat([adata_human_subset, adata_mouse_subset],
                              label='species')
    
    # Integration
    scvi.model.SCVI.setup_anndata(adata_combined, batch_key='species')
    vae = scvi.model.SCVI(adata_combined)
    vae.train()
    
    adata_combined.obsm["X_scVI"] = vae.get_latent_representation()
    
    return adata_combined
```

### Key Publications for Year 3

15. **Bergen V, et al.** (2020). Generalizing RNA velocity to transient cell states through dynamical modeling. *Nat Biotechnol*. 38:1408-1414.

16. **La Manno G, et al.** (2018). RNA velocity of single cells. *Nature*. 560:494-498.

17. **Lange M, et al.** (2022). CellRank for directed single-cell fate mapping. *Nat Methods*. 19:159-170.

18. **Haghverdi L, et al.** (2016). Diffusion pseudotime robustly reconstructs lineage branching. *Nat Methods*. 13:845-848.

19. **Wolf FA, et al.** (2019). PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells. *Genome Biol*. 20:59.

20. **Street K, et al.** (2018). Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. *BMC Genomics*. 19:477.

### Deliverables Year 3

1. **Temporal Trajectory Atlas**
   - Disease progression maps for each disorder
   - Early biomarker signatures
   - Critical transition points identified

2. **Cellular Clocks**
   - Staging models with gene signatures
   - Progression rate predictions

3. **Publications** (4-5 papers)
   - "Temporal dynamics of cellular responses in neurodegeneration"
   - "Early biomarkers from single-cell trajectories"
   - "Cross-species validation of disease mechanisms"
   - "RNA velocity reveals fate transitions in disease"

4. **Clinical Validation Studies**
   - Collaboration with clinical cohorts
   - Prospective biomarker validation

---

## Year 4: Therapeutic Target Identification & Mechanism Validation

### Research Questions
1. Which cell types and states are most druggable for intervention?
2. What are the compensatory vs maladaptive cellular responses?
3. Can we repurpose existing drugs based on cell-type-specific mechanisms?

### Hypotheses
- **H1**: Blocking microglial transition from homeostatic to disease-associated states will be neuroprotective
- **H2**: Enhancing astrocyte support functions while blocking reactive neurotoxic states represents viable therapeutic strategy
- **H3**: Targeting oligodendrocyte progenitor dysfunction can ameliorate white matter pathology

### Data Sources - Perturbation Studies

#### Perturbation Datasets

1. **Perturb-seq / CROP-seq Data**
   - CRISPR screens in brain cells
   - Available through GEO and CellxGene

2. **Drug Treatment scRNA-seq**
   - Post-mortem tissue from treated patients
   - In vitro drug response datasets

3. **Genetic Perturbation Studies**
   - Knockout/knockdown experiments
   - Disease-causing mutations

#### Drug & Protein Databases

4. **DrugBank** - https://go.drugbank.com
   - Comprehensive drug-target information

5. **ChEMBL** - https://www.ebi.ac.uk/chembl/
   - Bioactive molecules database

6. **BioGRID** - https://thebiogrid.org
   - Protein-protein interactions

7. **STRING** - https://string-db.org
   - Protein interaction networks

### Year 4 Protocol: Target Prioritization Using scverse

#### Step 1: Differential Expression Analysis

```python
def comprehensive_de_analysis(adata, condition_key='disease'):
    """Multi-method differential expression"""
    
    # Method 1: Wilcoxon (scanpy default)
    sc.tl.rank_genes_groups(
        adata, 
        condition_key,
        method='wilcoxon',
        key_added='rank_genes_wilcoxon'
    )
    
    # Method 2: t-test
    sc.tl.rank_genes_groups(
        adata,
        condition_key,
        method='t-test',
        key_added='rank_genes_ttest'
    )
    
    # Method 3: DESeq2-like (via diffxpy)
    import diffxpy.api as de
    
    test = de.test.wald(
        data=adata,
        formula_loc="~ 1 + disease",
        factor_loc_totest="disease"
    )
    
    # Combine results
    de_genes = test.summary()
    
    return adata, de_genes

def cell_type_specific_de(adata, celltype_key='cell_type', 
                          condition_key='disease'):
    """DE analysis for each cell type"""
    
    de_results = {}
    
    for celltype in adata.obs[celltype_key].unique():
        # Subset to cell type
        adata_subset = adata[adata.obs[celltype_key] == celltype].copy()
        
        # DE analysis
        sc.tl.rank_genes_groups(
            adata_subset,
            condition_key,
            method='wilcoxon'
        )
        
        # Extract results
        de_results[celltype] = sc.get.rank_genes_groups_df(
            adata_subset,
            group=None
        )
    
    return de_results
```

#### Step 2: Causal Inference

```python
def identify_driver_genes(adata, perturbation_data=None):
    """Identify causal driver genes vs passenger genes"""
    
    # Method 1: Perturb-seq analysis
    if perturbation_data:
        import pertpy as pt
        
        # Load perturbation data
        adata_perturb = perturbation_data
        
        # Calculate perturbation signatures
        pt_de = pt.tl.PerturbationDE(adata_perturb)
        pt_de.compare_conditions()
        
        # Identify hits
        hits = pt_de.get_significant_perturbations()
        
    # Method 2: Granger causality from temporal data
    from statsmodels.tsa.stattools import grangercausalitytests
    
    # Method 3: Transcription factor activity inference
    import decoupler as dc
    
    # Get TF-target gene sets
    net = dc.get_collectri(organism='human')
    
    # Estimate TF activities
    dc.run_mlm(
        mat=adata,
        net=net,
        source='source',
        target='target',
        weight='weight',
        verbose=True
    )
    
    # Method 4: Gene regulatory network inference
    import pyscenic
    # or use CellOracle for GRN with perturbation predictions
    
    return driver_genes

def prioritize_therapeutic_targets(adata, de_results, 
                                   druggability_scores):
    """Score and rank therapeutic targets"""
    
    # Scoring criteria:
    # 1. Effect size (fold change)
    # 2. Cell-type specificity
    # 3. Druggability
    # 4. Disease relevance (GWAS overlap)
    # 5. Safety (expression in critical tissues)
    
    target_scores = {}
    
    for gene in de_results.index:
        score = 0
        
        # Effect size
        fc = de_results.loc[gene, 'logfoldchanges']
        score += abs(fc) * 10
        
        # Cell-type specificity (higher = more specific)
        specificity = calculate_specificity(adata, gene)
        score += specificity * 20
        
        # Druggability
        if gene in druggability_scores:
            score += druggability_scores[gene] * 15
        
        # GWAS association
        if gene in gwas_genes:
            score += 25
        
        # Safety (penalize if highly expressed in heart, liver)
        safety_penalty = check_safety(gene)
        score -= safety_penalty
        
        target_scores[gene] = score
    
    # Rank targets
    ranked_targets = sorted(target_scores.items(), 
                           key=lambda x: x[1], 
                           reverse=True)
    
    return ranked_targets

def calculate_specificity(adata, gene):
    """Calculate cell-type specificity score"""
    
    # Jensen-Shannon specificity
    from scipy.spatial.distance import jensenshannon
    
    # Get expression per cell type
    celltype_expr = {}
    for ct in adata.obs['cell_type'].unique():
        mask = adata.obs['cell_type'] == ct
        celltype_expr[ct] = adata[mask, gene].X.mean()
    
    # Convert to probability distribution
    total = sum(celltype_expr.values())
    prob_dist = [v/total for v in celltype_expr.values()]
    uniform_dist = [1/len(celltype_expr)] * len(celltype_expr)
    
    # JS divergence
    js_div = jensenshannon(prob_dist, uniform_dist)
    
    return js_div
```

#### Step 3: Drug Repurposing Analysis

```python
def drug_repurposing_analysis(de_results, drug_database):
    """Identify repurposing candidates"""
    
    # Load drug-gene interaction database
    import pandas as pd
    drugbank = pd.read_csv(drug_database)
    
    # Method 1: Signature matching
    # Compare disease signature with drug-induced changes
    from scipy.stats import spearmanr
    
    disease_signature = de_results['logfoldchanges']
    
    drug_scores = {}
    for drug in drugbank['drug_name'].unique():
        drug_targets = drugbank[
            drugbank['drug_name'] == drug
        ]['target_gene'].tolist()
        
        # Calculate reversal score
        # Drugs that reverse disease signature score high
        reversal_score = 0
        for gene in drug_targets:
            if gene in disease_signature.index:
                # Negative correlation = reversal
                reversal_score -= disease_signature[gene]
        
        drug_scores[drug] = reversal_score
    
    # Method 2: Network proximity
    # Calculate network distance between drug targets and disease genes
    
    # Method 3: scDRS for disease-drug associations
    import scdrs
    
    return drug_scores

def validate_targets_in_silico(adata, target_genes, perturbation='knockdown'):
    """In silico validation using CellOracle"""
    
    # Requires CellOracle installation
    import celloracle as co
    
    # Build GRN
    oracle = co.Oracle()
    oracle.import_anndata_as_raw_count(adata)
    oracle.perform_PCA()
    oracle.knn_imputation()
    
    # Infer GRN
    # This requires additional TF binding data
    
    # Simulate perturbation
    oracle.simulate_shift(
        perturb_condition={target_genes[0]: perturbation},
        n_propagation=3
    )
    
    # Visualize predicted effects
    oracle.calculate_p_mass()
    oracle.suggest_genes()
    
    return oracle
```

#### Step 4: Pathway & Network Analysis

```python
def pathway_enrichment(gene_list, organism='human'):
    """Comprehensive pathway enrichment"""
    
    # Method 1: Gene Ontology
    import gseapy as gp
    
    enr_go = gp.enrichr(
        gene_list=gene_list,
        gene_sets=['GO_Biological_Process_2021'],
        organism='Human',
        cutoff=0.05
    )
    
    # Method 2: KEGG pathways
    enr_kegg = gp.enrichr(
        gene_list=gene_list,
        gene_sets=['KEGG_2021_Human'],
        organism='Human',
        cutoff=0.05
    )
    
    # Method 3: Reactome
    enr_reactome = gp.enrichr(
        gene_list=gene_list,
        gene_sets=['Reactome_2022'],
        organism='Human',
        cutoff=0.05
    )
    
    # Method 4: Using decoupler for pathway activity
    import decoupler as dc
    
    # Get pathway gene sets
    msigdb = dc.get_resource('MSigDB')
    
    # Calculate pathway activities
    dc.run_mlm(
        mat=adata,
        net=msigdb,
        source='geneset',
        target='genesymbol',
        verbose=True
    )
    
    return enr_go, enr_kegg, enr_reactome

def build_disease_network(target_genes, ppi_database):
    """Build protein-protein interaction network"""
    
    import networkx as nx
    import pandas as pd
    
    # Load PPI data
    ppi = pd.read_csv(ppi_database, sep='\t')
    
    # Filter to target genes
    ppi_filtered = ppi[
        (ppi['protein1'].isin(target_genes)) |
        (ppi['protein2'].isin(target_genes))
    ]
    
    # Build network
    G = nx.from_pandas_edgelist(
        ppi_filtered,
        source='protein1',
        target='protein2',
        edge_attr='score'
    )
    
    # Network analysis
    # Degree centrality
    degree_cent = nx.degree_centrality(G)
    
    # Betweenness centrality
    between_cent = nx.betweenness_centrality(G)
    
    # Community detection
    communities = nx.community.greedy_modularity_communities(G)
    
    # Identify hub genes
    hubs = sorted(degree_cent.items(), 
                 key=lambda x: x[1], 
                 reverse=True)[:20]
    
    return G, hubs, communities
```

### Key Publications for Year 4

21. **Dixit A, et al.** (2016). Perturb-Seq: Dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens. *Cell*. 167:1853-1866.

22. **Replogle JM, et al.** (2022). Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq. *Cell*. 185:2559-2575.

23. **Kamimoto K, et al.** (2023). Dissecting cell identity via network inference and in silico gene perturbation. *Nature*. 614:742-751.

24. **Holland CH, et al.** (2020). Transfer of regulatory knowledge from human to mouse for functional genomics analysis. *Biochim Biophys Acta Gene Regul Mech*. 1863:194431.

25. **Badia-i-Mompel P, et al.** (2022). decoupleR: ensemble of computational methods to infer biological activities from omics data. *Bioinformatics Adv*. 2:vbac016.

26. **Dugourd A, Saez-Rodriguez J.** (2019). Footprint-based functional analysis of multiomic data. *Curr Opin Syst Biol*. 15:82-90.

### Deliverables Year 4

1. **Target Portfolio**
   - 20+ prioritized therapeutic targets
   - Cell-type specific intervention strategies
   - Druggability assessments

2. **Drug Repurposing Candidates**
   - Ranked list of FDA-approved drugs
   - Mechanism-based predictions

3. **Publications** (3-4 papers)
   - "Systematic target identification from single-cell meta-analysis"
   - "Drug repurposing opportunities in neurodegeneration"
   - "Cell-type-specific therapeutic strategies"

4. **Experimental Validation**
   - Collaboration with experimental labs
   - Functional validation of top 3-5 targets

5. **Patent Applications**
   - Novel therapeutic targets
   - Combination therapy strategies

---

## Year 5: Clinical Translation & Precision Medicine Framework

### Research Questions
1. Can we stratify patients into molecular subtypes for precision treatment?
2. What cellular signatures predict treatment response?
3. How do genetic backgrounds modify cellular responses to disease?

### Hypotheses
- **H1**: AD patients can be stratified into "immune-predominant" vs "neuronal-predominant" subtypes with different progression rates
- **H2**: SCZ patients with excitatory neuron dysfunction signatures respond better to specific antipsychotics
- **H3**: Individual genetic risk profiles predict cellular vulnerability patterns and optimal therapeutic windows

### Data Sources - Clinical Integration

#### Clinical Trial Data

1. **Failed Trial Post-mortem Tissue**
   - Available through collaborations
   - Responder vs non-responder analyses

2. **Patient Cohorts with Genomics**
   - Combine scRNA-seq with WGS/WES
   - eQTL datasets at single-cell resolution

#### Biomarker Studies

3. **CSF & Blood Transcriptomics**
   - Correlate with brain cellular states
   - Longitudinal biomarker validation

4. **Electronic Health Records**
   - Genotype-phenotype associations
   - Treatment response data

### Year 5 Protocol: Precision Medicine Using scverse

#### Step 1: Molecular Subtyping

```python
def identify_disease_subtypes(adata, n_subtypes=3):
    """Identify molecular subtypes of disease"""
    
    # Method 1: Clustering on disease samples
    adata_disease = adata[adata.obs['disease_status'] == 'case'].copy()
    
    # Use patient-level pseudobulk for subtyping
    import pseudobulk
    
    pseudobulk_df = pseudobulk.pseudobulk(
        adata_disease,
        groupby=['patient_id', 'cell_type']
    )
    
    # Dimensionality reduction
    from sklearn.decomposition import PCA
    pca = PCA(n_components=50)
    pca_result = pca.fit_transform(pseudobulk_df)
    
    # Clustering
    from sklearn.cluster import KMeans
    kmeans = KMeans(n_clusters=n_subtypes, random_state=42)
    subtypes = kmeans.fit_predict(pca_result)
    
    # Add subtype labels
    patient_subtypes = pd.DataFrame({
        'patient_id': pseudobulk_df.index,
        'subtype': subtypes
    })
    
    # Map back to single cells
    adata_disease.obs = adata_disease.obs.merge(
        patient_subtypes,
        on='patient_id',
        how='left'
    )
    
    # Method 2: Topic modeling approach
    # Use LDA or NMF for soft clustering
    
    return adata_disease, patient_subtypes

def characterize_subtypes(adata, subtype_key='subtype'):
    """Characterize molecular features of each subtype"""
    
    # Cell composition differences
    composition = pd.crosstab(
        adata.obs[subtype_key],
        adata.obs['cell_type'],
        normalize='index'
    )
    
    # Differential expression between subtypes
    sc.tl.rank_genes_groups(adata, subtype_key, method='wilcoxon')
    
    # Pathway enrichment per subtype
    subtype_pathways = {}
    for subtype in adata.obs[subtype_key].unique():
        markers = sc.get.rank_genes_groups_df(
            adata, group=subtype
        ).head(200)['names'].tolist()
        
        pathways = pathway_enrichment(markers)
        subtype_pathways[subtype] = pathways
    
    # Clinical correlation
    # If clinical data available
    if 'progression_rate' in adata.obs.columns:
        from scipy.stats import kruskal
        
        stat, pval = kruskal(*[
            adata.obs[adata.obs[subtype_key] == st]['progression_rate']
            for st in adata.obs[subtype_key].unique()
        ])
        
        print(f"Subtypes differ in progression rate: p={pval}")
    
    return composition, subtype_pathways
```

#### Step 2: Genetic Integration (Cell-type eQTLs)

```python
def cell_type_eqtl_analysis(adata, genotype_data):
    """Cell-type-specific eQTL analysis"""
    
    # Requires genotype data for same individuals
    # Use tensorQTL for GPU-accelerated analysis
    import tensorqtl
    from tensorqtl import genotypeio, cis, trans
    
    # Prepare expression data
    phenotype_df = adata.to_df()
    phenotype_bed = tensorqtl.post.prepare_bed(phenotype_df)
    
    # Load genotypes
    pr = genotypeio.PlinkReader(genotype_data)
    genotype_df = pr.load_genotypes()
    variant_df = pr.bim.set_index('snp')
    
    # Calculate cis-eQTLs for each cell type
    eqtl_results = {}
    
    for celltype in adata.obs['cell_type'].unique():
        # Subset to cell type
        adata_ct = adata[adata.obs['cell_type'] == celltype]
        phenotype_ct = adata_ct.to_df()
        
        # Run tensorQTL
        cis_df = cis.map_cis(
            genotype_df,
            variant_df,
            phenotype_ct,
            covariates_df=None  # Add technical covariates
        )
        
        eqtl_results[celltype] = cis_df
    
    return eqtl_results

def polygenic_risk_scores(adata, gwas_summary, genotypes):
    """Calculate cell-type-specific PRS"""
    
    # Use scDRS for single-cell disease association
    import scdrs
    
    # Load GWAS data
    gene_list, gene_weight = scdrs.util.load_gene_list(gwas_summary)
    
    # Calculate disease scores
    scdrs.score_cell(
        adata=adata,
        gene_list=gene_list,
        gene_weight=gene_weight,
        ctrl_match_key='gene_mean_umi'
    )
    
    # Aggregate by cell type
    celltype_prs = adata.obs.groupby('cell_type')['norm_score'].mean()
    
    return celltype_prs
```

#### Step 3: Biomarker Development

```python
def identify_biomarkers(adata_brain, adata_blood):
    """Identify blood biomarkers reflecting brain states"""
    
    # Find genes expressed in both brain and blood
    common_genes = list(set(adata_brain.var_names) & 
                       set(adata_blood.var_names))
    
    # Correlate brain cell-type signatures with blood profiles
    from scipy.stats import spearmanr
    
    # Get brain signatures
    brain_signatures = {}
    for ct in adata_brain.obs['cell_type'].unique():
        mask = adata_brain.obs['cell_type'] == ct
        brain_signatures[ct] = adata_brain[mask, common_genes].X.mean(axis=0)
    
    # Correlate with blood
    blood_expr = adata_blood[:, common_genes].X.toarray()
    
    correlations = {}
    for ct, signature in brain_signatures.items():
        corrs = []
        for i in range(blood_expr.shape[0]):
            corr, _ = spearmanr(signature, blood_expr[i, :])
            corrs.append(corr)
        correlations[ct] = np.array(corrs)
    
    # Identify top correlated genes as biomarkers
    biomarkers = {}
    for ct in correlations:
        top_idx = np.argsort(np.abs(correlations[ct]))[-50:]
        biomarkers[ct] = [common_genes[i] for i in top_idx]
    
    return biomarkers

def validate_biomarkers(adata, biomarker_genes, clinical_outcome):
    """Validate biomarkers for clinical prediction"""
    
    from sklearn.ensemble import RandomForestClassifier
    from sklearn.model_selection import cross_val_score
    from sklearn.metrics import roc_auc_score, classification_report
    
    # Extract biomarker expression
    X = adata[:, biomarker_genes].X.toarray()
    y = adata.obs[clinical_outcome]
    
    # Train classifier
    clf = RandomForestClassifier(n_estimators=100, random_state=42)
    
    # Cross-validation
    cv_scores = cross_val_score(clf, X, y, cv=5, scoring='roc_auc')
    
    print(f"Cross-validation AUC: {cv_scores.mean():.3f} Â± {cv_scores.std():.3f}")
    
    # Feature importance
    clf.fit(X, y)
    feature_importance = pd.DataFrame({
        'gene': biomarker_genes,
        'importance': clf.feature_importances_
    }).sort_values('importance', ascending=False)
    
    return clf, feature_importance
```

#### Step 4: Treatment Response Prediction

```python
def predict_treatment_response(adata, treatment_data):
    """Predict treatment response from cellular profiles"""
    
    # Extract cellular features
    features = []
    
    # 1. Cell-type proportions
    celltype_props = adata.obs.groupby(
        ['patient_id', 'cell_type']
    ).size().unstack(fill_value=0)
    celltype_props = celltype_props.div(celltype_props.sum(axis=1), axis=0)
    features.append(celltype_props)
    
    # 2. Cell-type-specific gene expression
    for ct in adata.obs['cell_type'].unique():
        ct_expr = adata[adata.obs['cell_type'] == ct].to_df()
        ct_patient_expr = ct_expr.groupby(
            adata.obs[adata.obs['cell_type'] == ct]['patient_id']
        ).mean()
        features.append(ct_patient_expr)
    
    # 3. Pathway activities
    import decoupler as dc
    
    # Calculate pathway scores
    msigdb = dc.get_resource('MSigDB')
    dc.run_mlm(mat=adata, net=msigdb)
    pathway_scores = adata.obsm['mlm_estimate']
    pathway_patient = pd.DataFrame(pathway_scores).groupby(
        adata.obs['patient_id']
    ).mean()
    features.append(pathway_patient)
    
    # Combine features
    X = pd.concat(features, axis=1)
    
    # Match with treatment outcomes
    y = treatment_data['response']
    
    # Machine learning prediction
    from sklearn.model_selection import train_test_split
    from sklearn.ensemble import GradientBoostingClassifier
    
    X_train, X_test, y_train, y_test = train_test_split(
        X, y, test_size=0.2, random_state=42
    )
    
    model = GradientBoostingClassifier(n_estimators=100)
    model.fit(X_train, y_train)
    
    # Evaluate
    from sklearn.metrics import roc_auc_score
    y_pred_proba = model.predict_proba(X_test)[:, 1]
    auc = roc_auc_score(y_test, y_pred_proba)
    
    print(f"Treatment response prediction AUC: {auc:.3f}")
    
    return model
```

#### Step 5: Clinical Decision Support

```python
def create_patient_report(adata_patient, reference_atlas, 
                          subtype_model, biomarker_model):
    """Generate personalized patient report"""
    
    report = {}
    
    # 1. Molecular subtype
    subtype = subtype_model.predict(adata_patient)
    report['subtype'] = subtype[0]
    
    # 2. Cell composition analysis
    celltype_counts = adata_patient.obs['cell_type'].value_counts()
    report['cell_composition'] = celltype_counts.to_dict()
    
    # 3. Disease stage
    progression_score = adata_patient.obs['progression_score'].mean()
    report['disease_stage'] = 'Early' if progression_score < 0.3 else 'Late'
    
    # 4. Vulnerable cell populations
    vulnerable_cells = adata_patient.obs[
        adata_patient.obs['vulnerability_score'] > 0.7
    ]['cell_type'].value_counts()
    report['vulnerable_populations'] = vulnerable_cells.to_dict()
    
    # 5. Treatment recommendations
    treatment_response_prob = biomarker_model.predict_proba(
        adata_patient
    )
    report['treatment_recommendations'] = {
        'first_line': 'Drug A' if treatment_response_prob[0, 1] > 0.7 else 'Drug B',
        'confidence': float(treatment_response_prob[0, 1])
    }
    
    # 6. Biomarker levels
    biomarker_expr = adata_patient[:, biomarker_genes].X.mean(axis=0)
    report['biomarkers'] = dict(zip(biomarker_genes, biomarker_expr))
    
    # 7. Genetic risk factors
    if 'genetic_risk_score' in adata_patient.obs.columns:
        report['genetic_risk'] = adata_patient.obs['genetic_risk_score'].mean()
    
    # Generate PDF report
    # (Implementation depends on requirements)
    
    return report
```

### Key Publications for Year 5

27. **Zhang MJ, et al.** (2022). Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data. *Nat Genet*. 54:1572-1580.

28. **Aevermann B, et al.** (2021). Cell type discovery using single-cell transcriptomics: implications for ontological representation. *Hum Mol Genet*. 30:R178-R196.

29. **Eraslan G, et al.** (2022). Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function. *Science*. 376:eabl4290.

30. **Jerby-Arnon L, Regev A.** (2020). DIALOGUE maps multicellular programs in tissue from single-cell or spatial transcriptomics data. *Nat Biotechnol*. 40:1363-1372.

### Deliverables Year 5

1. **Clinical Tools**
   - Molecular subtyping algorithm
   - Cell-type-specific genetic risk scores
   - Treatment response prediction models

2. **Biomarker Panel**
   - Blood/CSF biomarkers validated in clinical cohorts
   - Diagnostic and prognostic markers
   - Companion diagnostics for drug trials

3. **Publications** (5-6 papers)
   - "Molecular taxonomy of neurological disorders"
   - "Cell-type-specific genetic architecture of brain diseases"
   - "Blood-based biomarkers reflecting brain cellular states"
   - "Precision medicine framework for neuropsychiatric disorders"
   - "Treatment response prediction from single-cell profiles"

4. **Clinical Decision Support Tool**
   - Web-based platform for clinicians
   - Patient report generation
   - Treatment recommendation system

5. **Patents & Commercialization**
   - Diagnostic methods
   - Biomarker panels
   - Treatment stratification algorithms

6. **Precision Medicine Initiative**
   - Pilot clinical trial
   - Prospective validation study
   - Industry partnerships

---

## Cross-Cutting Infrastructure & Resources

### Computing Infrastructure

#### High-Performance Computing

**Year 1-2 Setup:**
- Compute cluster with 256+ cores
- 1TB+ RAM
- 100TB+ storage
- GPU nodes (4x NVIDIA A100)

**Year 3-5 Scaling:**
- Cloud computing integration (AWS, GCP, Azure)
- Kubernetes for containerized workflows
- Distributed computing with Dask/Ray

#### Software Environment

```bash
# Create conda environment
conda create -n brain_meta_analysis python=3.10
conda activate brain_meta_analysis

# Core scverse packages
pip install scanpy squidpy anndata spatialdata
pip install muon scvi-tools

# GPU acceleration
pip install rapids-singlecell

# Additional tools
pip install pertpy decoupler cellrank scvelo
pip install GEOparse mygene biomart

# Machine learning
pip install scikit-learn xgboost lightgbm
pip install torch pytorch-lightning

# Statistical analysis
pip install statsmodels scipy
pip install diffxpy

# Visualization
pip install matplotlib seaborn plotly
pip install cellxgene

# Workflow
pip install snakemake nextflow
```

### Data Management

#### Database Structure

```python
# Recommended structure
/data
âââ raw/                    # Original downloaded data
â   âââ alzheimers/
â   âââ schizophrenia/
â   âââ als_ftd/
âââ processed/              # QC'd and normalized
â   âââ individual_studies/
â   âââ metadata/
âââ integrated/             # Batch-corrected
â   âââ full_atlas.h5ad
â   âââ disorder_specific/
âââ spatial/                # Spatial datasets
â   âââ visium/
â   âââ merfish/
âââ analysis/               # Analysis results
    âââ differential_expression/
    âââ trajectories/
    âââ networks/
```

### Collaboration Framework

#### Academic Collaborations

1. **Clinical Sites** (3-5 medical centers)
   - Sample collection
   - Clinical validation
   - Biomarker studies

2. **Experimental Labs** (5-10 groups)
   - Functional validation
   - Perturbation studies
   - Model systems

3. **Computational Groups**
   - Method development
   - Joint analyses
   - Tool integration

#### Industry Partnerships

1. **Pharma/Biotech**
   - Target validation
   - Drug screening
   - Clinical trial support

2. **Diagnostics Companies**
   - Biomarker commercialization
   - Assay development

### Training & Dissemination

#### Workshops & Training

- **Annual Workshop**: "Single-cell meta-analysis using scverse"
- **Online Tutorials**: YouTube channel with video guides
- **Documentation**: Comprehensive Jupyter notebooks

#### Community Building

- **Quarterly Webinars**: Latest findings and methods
- **Annual Symposium**: International meeting
- **Online Forum**: Discord/Slack for community support

### Funding Strategy

#### Year 1-2
- **NIH R01** (2-3 grants): $1.5-2M/year
  - R01 #1: Alzheimer's Disease focus
  - R01 #2: Schizophrenia/psychiatric disorders
  - R01 #3: ALS/FTD comparative analysis

- **Foundation Grants**: $500K/year
  - Alzheimer's Association
  - Michael J. Fox Foundation
  - Brain & Behavior Research Foundation

#### Year 3-4
- **NIH U01/U19** (Consortium): $3-5M/year
- **ERC Advanced Grant**: â¬2-3M
- **Industry Partnerships**: $1-2M/year

#### Year 5
- **NIH P01** (Program Project): $3-4M/year
- **SBIR/STTR** (Commercialization): $1-2M
- **Clinical Trial Support**: $2-3M

**Total Projected Funding**: $30-40M over 5 years

---

## Success Metrics

### Scientific Impact

**Publications:**
- 20-25 peer-reviewed papers in high-impact journals
- Nature, Science, Cell families: 8-10 papers
- Neurology/Psychiatry journals: 10-12 papers
- Methods papers: 2-3 papers

**Citations:**
- Target: 5,000+ citations by Year 5
- H-index increase: +10-15 points

**Presentations:**
- Keynote invitations: 10+ at major conferences
- Invited seminars: 20+ at universities/institutes

### Clinical Impact

**Therapeutic Development:**
- 3+ targets entering preclinical validation
- 1+ entering clinical trials
- 5+ drug repurposing candidates identified

**Biomarkers:**
- 2+ biomarker panels validated
- 1+ companion diagnostic in development

**Clinical Trials:**
- 1+ trial designed based on findings
- 2+ trials using stratification methods

### Resource Impact

**Data & Tools:**
- 50,000+ users of web portal
- 100+ citations of database papers
- 20+ independent labs using methods

**Open Science:**
- All data publicly available
- All code on GitHub
- Docker containers for reproducibility

**Community:**
- 500+ members in online community
- 10+ derived projects by other groups

### Training Impact

**Career Development:**
- 50% of trainees â faculty/senior industry positions
- 30+ researchers trained through workshops
- 10+ PhD theses completed

---

## Risk Mitigation Strategies

### Technical Risks

| Risk | Mitigation |
|------|-----------|
| Data quality heterogeneity | Rigorous QC pipeline; batch correction methods |
| Reproducibility across datasets | Require replication in 3+ cohorts |
| Computational scalability | GPU acceleration; cloud computing |
| Method obsolescence | Maintain flexibility for new technologies |

### Scientific Risks

| Risk | Mitigation |
|------|-----------|
| Negative results | Design studies with clear alternative hypotheses |
| Lack of validation samples | Build clinical partnerships early |
| Moving target (rapid field evolution) | Allocate 20% time for new methods |

### Funding Risks

| Risk | Mitigation |
|------|-----------|
| Grant rejection | Diversify funding sources |
| Budget cuts | Prioritize critical experiments |
| Industry partnership delays | Multiple partnerships simultaneously |

---

## Conclusion

This comprehensive 5-year research plan positions your laboratory at the forefront of single-cell meta-analysis in brain disorders. By systematically leveraging the scverse ecosystem and integrating data across multiple disorders, timepoints, and spatial contexts, you will:

1. **Create the definitive single-cell atlas** of brain disorders (>10M cells)
2. **Identify novel therapeutic targets** with unprecedented cell-type resolution
3. **Develop precision medicine tools** for clinical translation
4. **Establish your lab as a global hub** for computational neuroscience

The plan is ambitious yet achievable, building systematically from database construction through spatial analysis, temporal dynamics, target identification, to clinical translation. Each year builds on the previous, with clear deliverables and milestones.

**Key Success Factors:**
- Use of standardized, scalable scverse tools
- Focus on reproducibility and open science
- Strong clinical and experimental partnerships
- Balanced portfolio of disorders and approaches
- Clear path from discovery to translation

With dedicated execution of this plan, your lab will make transformative contributions to understanding and treating brain disorders, while training the next generation of computational neuroscientists.

---

## Appendix: Quick Reference Guides

### A. Essential scverse Commands

```python
# Load data
adata = sc.read_h5ad('data.h5ad')

# QC
sc.pp.calculate_qc_metrics(adata)
sc.pp.filter_cells(adata, min_genes=200)
sc.pp.filter_genes(adata, min_cells=3)

# Normalization
sc.pp.normalize_total(adata, target_sum=1e4)
sc.pp.log1p(adata)

# Feature selection
sc.pp.highly_variable_genes(adata)

# Dimensionality reduction
sc.pp.pca(adata)
sc.pp.neighbors(adata)
sc.tl.umap(adata)

# Clustering
sc.tl.leiden(adata)

# DE analysis
sc.tl.rank_genes_groups(adata, 'leiden')

# Visualization
sc.pl.umap(adata, color=['leiden', 'gene_name'])
```

### B. Key Datasets Summary Table

| Disorder | Dataset | Accession | Cells | Samples | Reference |
|----------|---------|-----------|-------|---------|-----------|
| AD | ROSMAP | Multiple | 1.3M | 283 | Mathys 2024 |
| AD | ssREAD | Various | 7.3M | 1,053 | Wang 2024 |
| SCZ | PsychENCODE | Multiple | 468K | 140 | Ruzicka 2024 |
| ALS/FTD | Motor Cortex | - | - | - | Pineda 2024 |
| PD | SNpc | - | 84K | 29 | Trzaskoma 2024 |
| HD | Striatum | - | - | - | Matsushima 2023 |
| Spatial | Visium DLPFC | GSE214979 | - | 12 | Maynard 2021 |

### C. Recommended Reading List

**Single-cell Methods:**
1. Hie et al. (2024). Nature Biotechnol. - Geometric sketching
2. Lotfollahi et al. (2022). Nature Mach Intell. - scVI
3. Wolf et al. (2019). Genome Biol. - PAGA

**Spatial Transcriptomics:**
4. Moses & Pachter (2022). Nat Rev Genet. - Spatial methods review
5. Rao et al. (2021). Science. - Slide-seq
6. Eng et al. (2019). Nature. - MERFISH

**Disease Studies:**
7. Mathys et al. (2023). Cell. - AD multiregion atlas
8. Ruzicka et al. (2024). Science. - SCZ multi-cohort
9. Tam et al. (2023). Nat Commun. - ALS/FTD C9orf72

### D. Useful Links

- **scverse**: https://scverse.org
- **scanpy docs**: https://scanpy.readthedocs.io
- **squidpy docs**: https://squidpy.readthedocs.io
- **GEO**: https://www.ncbi.nlm.nih.gov/geo/
- **Single Cell Portal**: https://singlecell.broadinstitute.org
- **AD Knowledge Portal**: https://adknowledgeportal.org
- **PsychENCODE**: http://psychencode.org

---

**Document Version**: 1.0  
**Last Updated**: October 2025  
**Copyright**: Md. Jubayer Hossain